Kintara Therapeutics (formerly DelMar Pharmaceuticals) to Present at the LD Micro 500 Virtual Conference on September 3rd, 2020 August 26, 2020 • 8:30 AM EDT
Kintara Therapeutics Announces Closing of Additional $2.2 Million Private Placement Priced at the Market August 25, 2020 • 8:30 AM EDT
Kintara Therapeutics Announces Additional $2.4 Million Private Placement Priced At-The-Market August 21, 2020 • 8:15 AM EDT
Kintara Therapeutics (formerly DelMar Pharmaceuticals) Regains Compliance with NASDAQ Minimum Bid Price Requirement August 21, 2020 • 8:00 AM EDT
Kintara Therapeutics (Formerly DelMar Pharmaceuticals) Announces Completion of Merger with Adgero Biopharmaceuticals and Closing of $19.6 Million Private Placement Priced At-The-Market August 20, 2020 • 8:30 AM EDT
DelMar Pharmaceuticals to Host Conference Call to Discuss Proposed Acquisition of Adgero Pharmaceuticals July 17, 2020 • 8:00 AM EDT
DelMar Pharmaceuticals Receives $500,000 Loan from the National Brain Tumor Society and National Foundation for Cancer Research to Support VAL-083's Participation in a Pivotal Study for Glioblastoma Sponsored by the Global Coalition for Adaptive Research June 24, 2020 • 8:30 AM EDT
DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed and Recurrent GBM at the AACR Virtual Annual Meeting II June 22, 2020 • 8:30 AM EDT